Name | Number of supported studies | Average coverage | |
---|---|---|---|
glutamatergic neuron | 3 studies | 39% ± 14% | |
type II pneumocyte | 3 studies | 52% ± 5% |
Insufficient scRNA-seq data for expression of AGBL1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
muscle | 100% | 1723.95 | 802 / 803 | 0% | 0 | 0 / 0 |
brain | 66% | 166.85 | 1743 / 2642 | 3% | 0.04 | 19 / 705 |
lung | 34% | 25.68 | 196 / 578 | 1% | 0.04 | 16 / 1155 |
prostate | 21% | 27.70 | 52 / 245 | 4% | 0.08 | 18 / 502 |
uterus | 2% | 1.45 | 4 / 170 | 2% | 0.11 | 10 / 459 |
tonsil | 0% | 0 | 0 / 0 | 2% | 0.05 | 1 / 45 |
esophagus | 1% | 2.87 | 16 / 1445 | 1% | 0.01 | 1 / 183 |
kidney | 0% | 0 | 0 / 89 | 1% | 0.04 | 13 / 901 |
ovary | 1% | 0.41 | 2 / 180 | 0% | 0.00 | 1 / 430 |
thymus | 1% | 1.23 | 5 / 653 | 0% | 0.00 | 2 / 605 |
breast | 1% | 1.31 | 3 / 459 | 0% | 0.01 | 4 / 1118 |
peripheral blood | 1% | 0.34 | 7 / 929 | 0% | 0 | 0 / 0 |
skin | 0% | 1.56 | 8 / 1809 | 0% | 0.01 | 1 / 472 |
stomach | 0% | 0.11 | 1 / 359 | 0% | 0.00 | 1 / 286 |
intestine | 1% | 0.22 | 5 / 966 | 0% | 0 | 0 / 527 |
adipose | 0% | 0.35 | 6 / 1204 | 0% | 0 | 0 / 0 |
adrenal gland | 0% | 0.16 | 1 / 258 | 0% | 0 | 0 / 230 |
blood vessel | 0% | 0.30 | 4 / 1335 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bladder | 0% | 0 | 0 / 21 | 0% | 0 | 0 / 504 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
heart | 0% | 0 | 0 / 861 | 0% | 0 | 0 / 0 |
liver | 0% | 0 | 0 / 226 | 0% | 0 | 0 / 406 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
pancreas | 0% | 0 | 0 / 328 | 0% | 0 | 0 / 178 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0035609 | Biological process | C-terminal protein deglutamylation |
GO_0006508 | Biological process | proteolysis |
GO_0035610 | Biological process | protein side chain deglutamylation |
GO_0005829 | Cellular component | cytosol |
GO_0008270 | Molecular function | zinc ion binding |
GO_0015631 | Molecular function | tubulin binding |
GO_0004181 | Molecular function | metallocarboxypeptidase activity |
Gene name | AGBL1 |
Protein name | Cytosolic carboxypeptidase 4 (EC 3.4.17.-) (EC 3.4.17.24) (ATP/GTP-binding protein-like 1) (Protein deglutamylase CCP4) tubulin-glutamate carboxypeptidase (EC 3.4.17.24) |
Synonyms | CCP4 |
Description | FUNCTION: Metallocarboxypeptidase that mediates deglutamylation of tubulin and non-tubulin target proteins. Catalyzes the removal of polyglutamate side chains present on the gamma-carboxyl group of glutamate residues within the C-terminal tail of tubulin protein. Specifically cleaves tubulin long-side-chains, while it is not able to remove the branching point glutamate. Also catalyzes the removal of polyglutamate residues from the carboxy-terminus of non-tubulin proteins such as MYLK. . |
Accessions | ENST00000441037.7 Q96MI9 A0A1B0GVQ2 ENST00000614907.3 |